메뉴 건너뛰기




Volumn 33, Issue 2, 2005, Pages 163-164

Role of recombinant activated factor VII in the management of life-threatening coagulopathic bleeding

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

EID: 17144385901     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0503300202     Document Type: Editorial
Times cited : (2)

References (14)
  • 2
    • 17144429108 scopus 로고    scopus 로고
    • Australian Government Department of Health and Aging Therapeutic Goods Administration Website: www.tga.gov.au
    • Australian Government Department of Health and Aging Therapeutic Goods Administration Website: www.tga.gov.au
  • 3
    • 5644273165 scopus 로고    scopus 로고
    • Recombinant activated factor VII for the treatment of life-threatening haemorrhage
    • Eikelboom JW, Bird R, Blythe D et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coag Fibrinol 2003; 14:713-717.
    • (2003) Blood Coag Fibrinol. , vol.14 , pp. 713-717
    • Eikelboom, J.W.1    Bird, R.2    Blythe, D.3
  • 4
    • 0033610715 scopus 로고    scopus 로고
    • Treatment of traumatic bleeding with recombinant factor VIIa
    • Kenet G, Walden R, Elad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354:1879.
    • (1999) Lancet , vol.354 , pp. 1879
    • Kenet, G.1    Walden, R.2    Elad, A.3    Martinowitz, U.4
  • 5
    • 0034778413 scopus 로고    scopus 로고
    • Recombinant activated factor VII for adjunctive hemorrhage control in trauma
    • Martinowitz U, Kenet G, Segal E et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431-439.
    • (2001) J. Trauma , vol.51 , pp. 431-439
    • Martinowitz, U.1    Kenet, G.2    Segal, E.3
  • 6
    • 0034928807 scopus 로고    scopus 로고
    • Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII
    • Moscardo F, Perez F, de la Rubia J, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 113:174-176.
    • (2001) Br. J. Haematol. , vol.113 , pp. 174-176
    • Moscardo, F.1    Perez, F.2    de la Rubia, J.3
  • 7
    • 0034120721 scopus 로고    scopus 로고
    • The effect of the administration of recombinant activated factor VII (NovoSeven() on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: The PROSE study
    • Friederich PW, Geerdink MGF, Spatoro M et al. The effect of the administration of recombinant activated factor VII (NovoSeven() on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study. Blood Coag Fibrin 2000; 11 (Suppl 1):S129-S132.
    • (2000) Blood Coag Fibrin , vol.11 , Issue.SUPPL. 1
    • Friederich, P.W.1    Geerdink, M.G.F.2    Spatoro, M.3
  • 8
    • 0034914327 scopus 로고    scopus 로고
    • An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
    • Hendriks HG, van der Maaten, de Wolf J et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001; 93:287-289.
    • (2001) Anesth. Analg. , vol.93 , pp. 287-289
    • Hendriks, H.G.1    van der Maaten de Wolf, J.2
  • 9
    • 0036795428 scopus 로고    scopus 로고
    • Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery
    • Von Heymann C, Hotz H, Konertz W Kox WJ, Spies C. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. J Cardiothor Vasc Anesth 2002; 16:615-616.
    • (2002) J. Cardiothor. Vasc. Anesth. , vol.16 , pp. 615-616
    • Von Heymann, C.1    Hotz, H.2    Konertz, W.3    Kox, W.J.4    Spies, C.5
  • 10
    • 0037320717 scopus 로고    scopus 로고
    • Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy
    • Shami VM, Caldwell SH, Hespenheide, EE. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transplantation 2003; 9:138-143.
    • (2003) Liver Transplantation , vol.9 , pp. 138-143
    • Shami, V.M.1    Caldwell, S.H.2    Hespenheide, E.E.3
  • 11
    • 17144382514 scopus 로고    scopus 로고
    • Recombinant activated factor VIIa (rFVIIa) use in massive transfusion and coagulopathy unresponsive to conventional therapy
    • Gowers CJD, Parr MJA. Recombinant activated factor VIIa (rFVIIa) use in massive transfusion and coagulopathy unresponsive to conventional therapy. Anaesth Intensive Care 2005; 33:196-200.
    • (2005) Anaesth. Intensive Care , vol.33 , pp. 196-200
    • Gowers, C.J.D.1    Parr, M.J.A.2
  • 12
    • 17144414679 scopus 로고    scopus 로고
    • Management of severe peri-operative coagulopathy: Role of recombinant activated factor VII
    • Keneally J, Jones M (Eds). Melbourne
    • Gibbs NM. Management of severe peri-operative coagulopathy: Role of recombinant activated factor VII. In Keneally J, Jones M (Eds). Australasian Anaesthesia 2003, Australian and New Zealand College of Anaesthetists, Melbourne, 2003, pp. 137-147.
    • (2003) Australasian Anaesthesia 2003, Australian and New Zealand College of Anaesthetists , pp. 137-147
    • Gibbs, N.M.1
  • 13
    • 0842277796 scopus 로고    scopus 로고
    • Safety profile of recombinant factor VIIa
    • Roberts HR, Monroe DM, Hoffman M. Safety profile of recombinant factor VIIa. Semin Hematol 2004; 41(Suppl 1): 101-108.
    • (2004) Semin. Hematol. , vol.41 , Issue.SUPPL. 1 , pp. 101-108
    • Roberts, H.R.1    Monroe, D.M.2    Hoffman, M.3
  • 14


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.